Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.6320
+0.0010 (0.16%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $7.83 million as of July 24, 2026. Its market cap has decreased by -26.69% in one year.
Market Cap
7.83M
Enterprise Value
-38.64M
1-Year Change
-26.69%
Ranking
Category
Stock Price
$0.63
ChartMarket Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $7.83M, a decrease of -58.67%. That is a compound annual growth rate of -19.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 7.83M | 31.18% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quoin Pharmaceuticals | 8.78M |
| Immuron | 8.65M |
| BioRestorative Therapies | 7.96M |
| CNS Pharmaceuticals | 7.91M |
| Processa Pharmaceuticals | 7.89M |
| Traws Pharma | 7.88M |
| MetaVia | 7.80M |
| Can-Fite BioPharma | 7.34M |